Omid Farokhzad
Chief Executive Officer bij SEER, INC.
Vermogen: 10 M $ op 31-03-2024
Profiel
Oprichter van 5 verschillende bedrijven, waaronder: Seer, Inc. (Californië), Selecta Biosciences, Inc. en DNIB Unwind, Inc. Omid C. Farokhzad is ondernemer en is Chairman & Chief Executive Officer voor Seer, Inc. (Californië) (dat hij in 2017 oprichtte). Hij zit ook in de raad van bestuur van Placon Therapeutics, Inc. In zijn vorige carrière was hij voorzitter voor Selecta Biosciences, Inc. (hij richtte het bedrijf op in 2007), Associate Professor aan de Harvard Medical School, Directeur bij DNIB Unwind, Inc. en Directeur bij Tarveda Therapeutics, Inc. Dr. Farokhzad behaalde een doctoraat en een graduaatsdiploma aan de Boston University School of Medicine en een MBA aan het Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SEER, INC.
87.67% | 31-12-2023 | 3 555 195 ( 87.67% ) | 7 M $ | 31-03-2024 |
SEER, INC. CLASS A
2.37% | 07-03-2024 | 1 436 285 ( 2.37% ) | 3 M $ | 31-03-2024 |
SENTI BIOSCIENCES, INC.
4.26% | 16-06-2023 | 1 947 403 ( 4.26% ) | 734 171 $ | 31-03-2024 |
Actieve functies van Omid Farokhzad
| Bedrijven | Functie | Begin |
|---|---|---|
| SEER, INC. | Chief Executive Officer | 01-03-2018 |
| SENTI BIOSCIENCES, INC. | Director/Board Member | 08-06-2022 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Director/Board Member | - |
| Xlink Therapeutics, Inc. | Founder | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Founder | - |
| Xira Connect, Inc. | Director/Board Member | 01-08-2019 |
Eerdere bekende functies van Omid Farokhzad
| Bedrijven | Functie | Einde |
|---|---|---|
| DYNC SPL | Chairman | 01-06-2022 |
| CARTESIAN THERAPEUTICS, INC. | Founder | 19-11-2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Founder | 01-01-2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Omid Farokhzad
| MIT Sloan School of Management | Masters Business Admin |
| Boston University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SEER, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The private company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Dynamics Special Purpose Corp. is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded on March 1, 2021 and is headquartered in Redwood City, CA. | Finance |
| Xlink Therapeutics, Inc. | |
| Xira Connect, Inc. | |
| Senti Biosciences, Inc. |
